Table 1.
Characteristics of the participants at study entry.
| Participant | ||
|---|---|---|
| ID (W = Woman/M = Man) | A (W) | B (M) |
| Age (years) | 75 | 74 |
| Years since PD diagnosis | 12 | 17 |
| Hoehn and Yahr Stage | 3 | 3 |
| Use of medications # | 3 | 8 |
| Living environment and use of assistive device | Home, with partner, with assistive device for outdoor walking only | Home, with partner, without walking aid |
| History of falls (n past year) | 14 | 3 |
| History of falls (n past month) | 1 | 0 |
| Balance (Mini-Best Test, n/28) * | 11 | 17 |
| Anticipatory (n/6) | 1 | 4 |
| Reactive postural control (n/6) | 0 | 2 |
| Sensory orientation (n/6) | 4 | 2 |
| Dynamic gait (n/10) | 6 | 9 |
| Global cognition (MoCA, n/30) ** | 20 | 26 |
| Quality of life (PDQ-39, n/100) *** | 78 | 68 |
# Levodopa, COMT inhibitors, MAO-B inhibitors, dopamine agonists, anticholinergics, vasopressors, and/or antidepressants (considered continuous-use medication only); * Mini-Best (Mini Balance Evaluation Systems Test) has 14 items (distributed over four categories), each of them scored from 0 to 2 (0 indicating the lowest and 2 the highest level of function) with a total score range between 0–28; ** MoCA (Montreal Cognitive Assessment) score ranges between 0–30 with >26 considered to be normal, 18–25 indicating mild cognitive impairment, 10–17 indicating moderate cognitive impairment, and <10 indicating severe cognitive impairment; *** PDQ-39 Parkinson’s Disease Questionnaire-39, scored 0−100 (100 = maximum level of problems), the higher score indicating the worst quality of life. Item sub-scores can range between 0 and 4 (0 = never; 1 = seldom; 2 = sometimes; 3 = often; and 4 = always or cannot do at all).